Suppression of collagen synthesis by Dicer gene silencing in hepatic stellate cells

Yu,Fujun; Lin,Zhuo; Zheng,Jianjian; Gao,Shenmeng; Lu,Zhongqiu; Dong,Peihong

doi:10.3892/mmr.2013.1866

Suppression of collagen synthesis by Dicer gene silencing in hepatic stellate cells

Authors:
- Fujun Yu
- Zhuo Lin
- Jianjian Zheng
- Shenmeng Gao
- Zhongqiu Lu
- Peihong Dong
View Affiliations

Affiliations: Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China, Wenzhou Key Laboratory of Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China, Laboratory of Internal Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China, Emergency Department, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China
Published online on: December 16, 2013 https://doi.org/10.3892/mmr.2013.1866
Pages: 707-714

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

MicroRNAs (miRNAs) have emerged as important mediators of hepatic stellate cells (HSCs) and are pivotal in the pathogenesis of liver fibrosis. Dicer, the key enzyme in the RNA interference (RNAi) pathway, is involved in cutting precursor miRNAs to functionally mature forms. Emerging evidence has demonstrated that Dicer expression is dysregulated in embryo development and tumors. In the present study, we aimed to address whether Dicer expression was correlated with the activity of HSCs. We used a recombinant lentivirus to generate short hairpin RNAs (shRNAs) targeting Dicer. The mRNA and protein expression of Dicer was effectively inhibited by three pairs of Dicer shRNA vectors, of which the shRNA1 vector exhibited the strongest inhibitory effect. The shRNA1 vector demonstrated a marked inhibitory effect on the activity of HSCs, resulting in the reduction of cell proliferation and the decrease of fibrosis-related genes, including type Ⅰ collagen (Col1A1), α-smooth muscle actin (α-SMA) and tissue inhibitor of metalloproteinases (TIMP). The mRNA expression of Col1A1, α-SMA and TIMP were decreased by 60, 56 and 49%, respectively. The protein expression was reduced by 56, 52 and 42%, respectively. Additionally, the inhibition of Dicer resulted in a decrease of miR-138, -143, -140 and -122 levels, of which miR-138 exhibited the strongest decline. The firefly luciferase reporter experiments and RT-PCR indicated that phosphatase and tension homolog deleted on chromosome 10 (PTEN), Ras GTPase activating-like protein 1 (RASAL1), acyl-CoA synthetase long-chain family member 1 (ACSL1) and p27 3' untranslated region sequences were targeted by miR-138, -143, -140 and -122, respectively. Taken together, the present study contributes important new findings for the role of Dicer‑mediated miRNA processing in collagen synthesis of HSCs, which may serve as a foundation for RNAi study of liver fibrosis in vivo.

View Figures

View References

1	Hsu YC, Lin JT, Chen TT, Wu MS and Wu CY: Long-term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis: a 10-year nationwide cohort study. Hepatology. 56:698–705. 2012.PubMed/NCBI
2	Li L, Yu C and Li Y: Endoscopic band ligation versus pharmacological therapy for variceal bleeding in cirrhosis: a meta-analysis. Can J Gastroenterol. 25:147–155. 2011.PubMed/NCBI
3	Qin T, Xia J, Ren H, Zhou H, Tang B and Shao Z: Liver cirrhosis as a predisposing condition for Legionnaires' disease: a report of four laboratory-confirmed cases from China. J Med Microbiol. 61:1023–1028. 2012. View Article : Google Scholar
4	Wang SB, Wang JH, Chen J, Giri RK and Chen MH: Natural history of liver cirrhosis in south China based on a large cohort study in one center: a follow-up study for up to 5 years in 920 patients. Chin Med J (Engl). 125:2157–2162. 2012.PubMed/NCBI
5	Giannone FA, Baldassarre M, Domenicali M, et al: Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl(4)-induced advanced cirrhosis. Lab Invest. 92:384–395. 2012. View Article : Google Scholar : PubMed/NCBI
6	Madro A, Czechowska G, Slomka M, Celinski K, Szymonik-Lesiuk S and Kurzepa J: The decrease of serum MMP-2 activity corresponds to alcoholic cirrhosis stage. Alcohol. 46:155–157. 2012. View Article : Google Scholar : PubMed/NCBI
7	Wirkowska A and Paczek L: Liver fibrosis and cirrhosis--selected cytokines, growth factors and proteins. Part II Przegl Lek. 68:228–230. 2011.(In Polish).
8	Oliveira-Junior MC, Monteiro AS, Leal-Junior EC, et al: Low-level laser therapy ameliorates CCl(4)-induced liver cirrhosis in rats. Photochem Photobiol. 89:173–178. 2013. View Article : Google Scholar : PubMed/NCBI
9	Lee JK, Kim JH and Shin HK: Therapeutic effects of the oriental herbal medicine Sho-saiko-to on liver cirrhosis and carcinoma. Hepatol Res. 41:825–837. 2011. View Article : Google Scholar : PubMed/NCBI
10	Cao S, Yaqoob U, Das A, et al: Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells. J Clin Invest. 120:2379–2394. 2010. View Article : Google Scholar : PubMed/NCBI
11	Iizuka M, Ogawa T, Enomoto M, et al: Induction of microRNA-214-5p in human and rodent liver fibrosis. Fibrogenesis Tissue Repair. 5:122012. View Article : Google Scholar : PubMed/NCBI
12	He Y, Huang C, Sun X, Long XR, Lv XW and Li J: MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4. Cell Signal. 24:1923–1930. 2012. View Article : Google Scholar : PubMed/NCBI
13	Noetel A, Kwiecinski M, Elfimova N, Huang J and Odenthal M: microRNA are central players in anti- and profibrotic gene regulation during liver fibrosis. Front Physiol. 3:492012. View Article : Google Scholar : PubMed/NCBI
14	Ogawa T, Enomoto M, Fujii H, et al: MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis. Gut. 61:1600–1609. 2012. View Article : Google Scholar : PubMed/NCBI
15	Dueck A, Ziegler C, Eichner A, Berezikov E and Meister G: microRNAs associated with the different human Argonaute proteins. Nucleic Acids Res. 40:9850–9862. 2012. View Article : Google Scholar : PubMed/NCBI
16	Gurtan AM, Lu V, Bhutkar A and Sharp PA: In vivo structure-function analysis of human Dicer reveals directional processing of precursor miRNAs. RNA. 18:1116–1122. 2012. View Article : Google Scholar : PubMed/NCBI
17	Andersson T, Rahman S, Sansom SN, et al: Reversible block of mouse neural stem cell differentiation in the absence of dicer and microRNAs. PLoS One. 5:e134532010. View Article : Google Scholar : PubMed/NCBI
18	Chiosea S, Jelezcova E, Chandran U, et al: Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am J Pathol. 169:1812–1820. 2006. View Article : Google Scholar : PubMed/NCBI
19	Vaksman O, Hetland TE, Trope' CG, Reich R and Davidson B: Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma. Hum Pathol. 43:2062–2069. 2012. View Article : Google Scholar : PubMed/NCBI
20	Zhang X, Cairns M, Rose B, et al: Alterations in miRNA processing and expression in pleomorphic adenomas of the salivary gland. Int J Cancer. 124:2855–2863. 2009. View Article : Google Scholar : PubMed/NCBI
21	Martin MG, Payton JE and Link DC: Dicer and outcomes in patients with acute myeloid leukemia (AML). Leuk Res. 33:e1272009. View Article : Google Scholar : PubMed/NCBI
22	Wu JF, Shen W, Liu NZ, et al: Down-regulation of Dicer in hepatocellular carcinoma. Med Oncol. 28:804–809. 2011. View Article : Google Scholar : PubMed/NCBI
23	Lakner AM, Steuerwald NM, Walling TL, et al: Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis. Hepatology. 56:300–310. 2012. View Article : Google Scholar : PubMed/NCBI
24	Uyama N, Iimuro Y, Kawada N, et al: Fascin, a novel marker of human hepatic stellate cells, may regulate their proliferation, migration, and collagen gene expression through the FAK-PI3K-Akt pathway. Lab Invest. 92:57–71. 2012. View Article : Google Scholar
25	Ramachandran P and Iredale JP: Liver fibrosis: a bidirectional model of fibrogenesis and resolution. QJM. 105:813–817. 2012. View Article : Google Scholar
26	Takashima M, Parsons CJ, Ikejima K, Watanabe S, White ES and Rippe RA: The tumor suppressor protein PTEN inhibits rat hepatic stellate cell activation. J Gastroenterol. 44:847–855. 2009. View Article : Google Scholar : PubMed/NCBI
27	Bian EB, Huang C, Ma TT, et al: DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell activation and liver fibrogenesis in rats. Toxicol Appl Pharmacol. 264:13–22. 2012. View Article : Google Scholar : PubMed/NCBI
28	Tao H, Huang C, Yang JJ, et al: MeCP2 controls the expression of RASAL1 in the hepatic fibrosis in rats. Toxicology. 290:327–333. 2011. View Article : Google Scholar : PubMed/NCBI
29	Li WQ, Chen C, Xu MD, et al: The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats. FEBS J. 278:1522–1532. 2011. View Article : Google Scholar : PubMed/NCBI
30	Wang B, Li W, Guo K, Xiao Y, Wang Y and Fan J: miR-181b promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients. Biochem Biophys Res Commun. 421:4–8. 2012. View Article : Google Scholar : PubMed/NCBI